Coinfection with Hepatitis C Virus and HIV: More than Double Trouble

被引：6
作者：
Piroth, Lionel [1 ]
机构：
[1] CHU Dijon, Dept Infectiol, F-21079 Dijon, France
来源：
CLINICAL INFECTIOUS DISEASES | 2009年 / 49卷 / 04期
关键词：
ACTIVE ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; DISEASE PROGRESSION; T-CELLS; VIROLOGICAL SUPPRESSION; POSITIVE PATIENTS; VIRAL-HEPATITIS; HCV COINFECTION; COHORT; IMPACT;
D O I：
10.1086/603558
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：623 / 625
页数：3
相关论文
共 34 条
  • [1] Evaluating the impact of hepatitis C virus (HCV) on highly active Antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: Role of HCV on expression of primed/memory T cells
    Al-Harthi, L
    Voris, J
    Du, W
    Wright, D
    Nowicki, M
    Frederick, T
    Landay, A
    Kovacs, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (09) : 1202 - 1210
  • [2] Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: Data from the HIV Atlanta VA Cohort Study
    Anderson, KB
    Guest, JL
    Rimland, D
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) : 1507 - 1513
  • [3] Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin
    Bani-Sadr, Firouze
    Goderel, Isabelle
    Lapidus, Nathanael
    Driss, Henda
    Simon, Anne
    Rosenthal, Eric
    Morand, Patrice
    Lunel-Fabiani, Francoise
    Pol, Stanislas
    Cacoub, Patrice
    Perronne, Christian
    Carrat, Fabrice
    [J]. AIDS, 2008, 22 (11) : 1385 - 1387
  • [4] Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort
    Braitstein, P
    Justice, A
    Bangsberg, DR
    Yip, B
    Alfonso, V
    Schechter, MT
    Hogg, RS
    Montaner, JSG
    [J]. AIDS, 2006, 20 (03) : 323 - 331
  • [5] Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy
    Bräu, N
    Salvatore, M
    Ríos-Bedoya, CF
    Fernández-Carbia, A
    Paronetto, F
    Rodríguez-Orengo, JF
    Rodríguez-Torres, M
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 (01) : 47 - 55
  • [6] Clinical outcomes of first antiretroviral regimen in HIV/hepatitis C virus co-infection
    Cooper, CL
    Breau, C
    LaRoche, A
    Lee, C
    Garber, G
    [J]. HIV MEDICINE, 2006, 7 (01) : 32 - 37
  • [7] Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection
    Cooper, Curtis L.
    Mills, Ed
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (08) : 546 - 550
  • [8] The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy
    Dorrucci, M
    Valdarchi, C
    Suligoi, B
    Zaccarelli, M
    Sinicco, A
    Giuliani, M
    Vlahov, D
    Pezzotti, P
    Rezza, G
    [J]. AIDS, 2004, 18 (17) : 2313 - 2318
  • [9] El-Serag HB, 2003, AM J GASTROENTEROL, V98, P167, DOI 10.1111/j.1572-0241.2003.07176.x
  • [10] CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater
    Gras, Luuk
    Kesselring, Anouk M.
    Griffin, James T.
    van Sighem, Ard I.
    Fraser, Christophe
    Ghani, Azra C.
    Miedema, Frank
    Reiss, Peter
    Lange, Joep M. A.
    de Wolf, Frank
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (02) : 183 - 192
1234